Etophylline BP 84 point 7 mg and theophylline IP 25 point 3 mg per ml 2 ml injection,Shark liver oi
Indian Army
Bid Publish Date
19-Feb-2026, 1:19 pm
Bid End Date
02-Mar-2026, 3:00 pm
Value
₹49,900
Location
Progress
Quantity
167
Category
Etophylline BP 84 point 7 mg and Theophylline IP 25 point 3 mg per ml per 2 ml Inj
Bid Type
Two Packet Bid
The Indian Army (Department Of Military Affairs) invites bids for the supply of five injectable medical products, including Etophylline BP 84.7 mg and Theophylline IP 25.3 mg per ml per 2 ml injection, Phytomenadione Vitamin K 1 mg per 0.5 ml injection, Tenecteplase 40 mg, Rabies Antiserum 1500 IU per 5 ml, and Potassium Chloride 15% intravenous injection (10 ml ampoule, approx. 1.5 g). Estimated value is ₹49,900.00. The tender emphasizes quantity variation up to 25% and requires bidder financial stability. GST considerations are to be verified by bidders. No explicit start/end dates or exact delivery windows are provided in the data.
– Location and procurement scope: Indian Army medical procurement in India; 5 injectable products with specified dosages.
– Key differentiator: Option clause enabling up to 25% quantity variation and extended delivery timelines if exercised.
– Unique aspects: This tender aggregates diverse critical injectable products under a single procurement event, with GST treatment left to bidders.
Five injectable products with specific dosages/strengths
Quantities not specified; 25% variation allowed
Delivery terms based on last date of original DO; minimum 30 days for extended delivery
GST handling by bidder; actuals or lower of quoted rate
No explicit standards listed; rely on general pharmacopoeial/regulatory compliance
Quantity variation up to 25% during contract; delivery window adjustments governed by formula
Bidder must demonstrate financial soundness and not be in liquidation or receivership
GST payable by bidder; reimbursement strategy disclosed; verify applicable GST rates
GST handling by bidder; reimbursement at actuals or lower quoted rate; no explicit advance terms in data
Delivery period begins from last date of original delivery order; extended time based on (additional/original) × original period with minimum 30 days
Not specified in data; implied standard procurement penalties may apply per Indian Army terms
Not under liquidation, court receivership, or similar proceedings
Ability to supply injectable pharmaceuticals meeting regulatory requirements
GST registration and compliance capable bidder
Main Document
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS
Indian Army
N/a
BHOPAL, MADHYA PRADESH
Indian Army
HYDERABAD, TELANGANA
Indian Army
MATHURA, UTTAR PRADESH
Dg Armed Forces Medical Service
Tender Results
Loading results...
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) |
|---|---|---|---|---|---|---|
| 1 | Etophylline BP 84 point 7 mg and Theophylline IP 25 point 3 mg per ml per 2 ml Inj | Etophylline BP 84.7 mg and Theophylline IP 25.3 mg per ml, 2 ml Inj | 100 | amp | singh.suhail | 15 |
| 2 | Phytomenadione Vit K 1mg per 0 point 5 ml Inj | Phytomenadione Vit K 1mg per 0 point 5 ml Inj | 30 | no | singh.suhail | 15 |
| 3 | Inj Tenecteplase 40 mg | Inj Tenecteplase 40 mg | 2 | vial | singh.suhail | 15 |
| 4 | Rabies Antiserum 1500IU per 5ml | Rabies Antiserum 1500IU/5ml | 5 | vial | singh.suhail | 15 |
| 5 | Potassium Chloride 15 percent Inj IV amp of 10 ml 1 point 5gm | Potassium Chloride 15% Inj (IV) amp of 10 ml (1.5gm) | 30 | amp | singh.suhail | 15 |
Discover companies most likely to bid on this tender
GST registration certificate
PAN card
Experience certificates for pharmaceutical injections (where applicable)
Financial statements or business finances demonstrating solvency
EMD submission details (if applicable per policy)
Technical bid documents and product specifications
OEM authorizations or authorized distributorships (where required by Indian Army)
Any certifications for sterile injectables or pharmacopoeial compliance
Key insights about UTTARAKHAND tender market
Bidders must register, submit GST and PAN documents, provide financial statements, and furnish technical bids with product specifications for all five injectables. Include OEM authorizations where required, and ensure compliance with GST rules. The tender allows 25% quantity variation and requires adherence to delivery timelines.
Required documents include GST certificate, PAN card, experience certificates for injectables, financial statements, EMD submission details, technical bid with product specs, OEM authorization if applicable, and any sterilization/quality certifications relevant to the injectable products.
Delivery starts from the last date of the original delivery order. If quantity increases, the extended delivery time is calculated as (additional quantity/original quantity) × original delivery period, with a minimum of 30 days. The purchaser may further extend within contracted rates.
The items include Etophylline BP 84.7 mg and Theophylline IP 25.3 mg per ml per 2 ml injection, Phytomenadione Vitamin K 1 mg per 0.5 ml injection, Tenecteplase 40 mg, Rabies Antiserum 1500 IU per 5 ml, and Potassium Chloride 15% intravenous injection in a 10 ml ampoule.
Bidders must verify applicable GST; the authority will reimburse GST at actual rates or the lower quoted rate, whichever is lower. Ensure GST compliance across all five injectable product lines and maintain accurate tax documentation during submission.
Applicants must not be in liquidation or similar proceedings, demonstrate financial stability, and provide experience certificates for supplying injectable medicines. OEM authorizations are required where specified, and bids should align with pharmacopoeial/regulatory standards for medical injectables.
The purchaser may alter the order quantity by up to 25% at contract placement and during currency at contracted rates. The formula for delivery extension uses (increased quantity ÷ original quantity) × original delivery period, with a minimum of 30 days.
Tenecteplase is tendered at 40 mg; Rabies Antiserum is 1500 IU per 5 ml. Suppliers must ensure regulatory compliance, sterility, cold-chain integrity, and appropriate labeling as per pharmacopoeial standards, and provide supporting certificates with the bid.
Sign up now to access all documents
Main Document
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS